학술논문

Patients with STAT1 Gain-of-function Mutations Display Increased Apoptosis which is Reversed by the JAK Inhibitor Ruxolitinib
Document Type
Article
Source
In: Journal of Clinical Immunology. (Journal of Clinical Immunology, May 2024, 44(4))
Subject
Language
English
ISSN
15732592
02719142